Oncotarget · 2017 · 24 citations · 29 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer Molecular PathologyCancer ProgressionMalignant NeoplasmsMetastatic Breast CancerOncogenic Signaling PathwaysBreast Cancer HistologyBreast Cancer HistopathologyBreast Cancer ProgressionCancer Signaling PathwaysMetastatic Breast Cancer BiologyOncogenic TransformationP16ink4a PathwayP16ink4a Regulation
// Xiaojing Yang 1 , Yi Sun 1 , Hongling Li 1 , Yuhui Shao 1 , Depeng Zhao 2 , Weiwei Yu 1 , Jie Fu 1 1 Department of Radiation Oncology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, 200233, China 2 Department of Obstetrics, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040, P.R. China Correspondence to: Jie Fu, email: sixshanghai6@126.com Keywords: CtBP2, p16 INK4A , breast cancer, proliferation, migration Received: September 27, 2016 Accepted: February 01, 2017 Published: February 16, 2017 ABSTRACT C-terminal binding protein-2 (CtBP2) enhances cancer proliferation and metastasis. The role and mechanism of CtBP2 in breast cancer remains to be elucidated. Western blot and immunochemistry were employed to evaluate the level of CtBP2 and p16 INK4A in breast cancer. Genetic manipulation was used to study the expression of p16 INK4A and its downstream genes regulated by CtBP2. Functional assays, including colony formation, wound healing, transwell invasion, anchorage-independent growth assay and a xenograft tumor model were used to determine the oncogenic role of CtBP2 in breast cancer progression. The expression of CtBP2 was increased in breast cancer tissues and cell lines. The expression of p16 INK4A were inversely correlated CtBP2 ( r 2 = 0.43, P < 0.01). The expression of both CtBP2 and p16 INK4A were significantly related to histological differentiation ( P < 0.01 and P = 0.004, respectively) and metastasis ( P = 0.046 and 0.047, respectively). The overall survival rate was lower in patients with increased CtBP2 expression and lower p16 INK4A expression. Knockdown of CtBP2 resulted in the activation of p16 INK4A and down–regulation of cell cycle regulators cyclin D, cyclin E and cyclin-dependent kinase 2 and 4. This down-regulation also led to a decreased transition of the G1-S phase in breast cancer cells. Moreover, gain-of-function experiments showed that CtBP2 suppressed p16 INK4A and matrix metalloproteinase-2, subsequently enhancing the migration in breast cancer. However, the silence of CtBP2 abrogated this effect. Collectively, these findings provide insight into the role CtBP2 plays in promoting proliferation and migration in breast cancer by the inhibition of p16 INK4A .
29
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
Alexander Kamb, Nelleke A. Gruis, Jane Weaver-Feldhaus et al. · Science · 1994 · 2.8K citations
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Tsutomu Nobori, Kaoru Miura, David Wu et al. · Nature · 1994 · 1.8K citations
GATA Transcription Factors and Cancer
Rui Zheng, Gerd A. Blobel · Genes & Cancer · 2010 · 280 citations · Full text